Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant
2 clinical trials · Condition
◉ Watch Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant
| Record | Firm | Date |
|---|---|---|
| Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM (NCT02428660) | Genelex Corporation | 2015-02-01 |
| Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE) (NCT01778907) | University of Groningen | 2013-02-01 |
Track Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant automatically
Every clearance here is in the API, with alerts when new ones post.